Month: February 2025
Stocks making the biggest moves premarket: Ford, Eli Lilly, Honeywell, Arm Holdings and more
Check out the companies making headlines in premarket trading. Ford — The automaker’s shares dropped more than 5% in premarket trading after the company issued soft 2025 guidance , citing “headwinds related to market factors.” Ford did beat Wall Street’s fourth-quarter expectations, however. Bristol Myers Squibb — Shares pulled back nearly 6% after its full-year […]
Read More
How the U.S. has used tariffs through history — and why Trump is different, economists say
Key Points The U.S. has used tariffs since its founding in the 18th century. They were primarily a way to raise revenue in the nation’s early days. Later, tariffs were largely used to restrict imports or as a bargaining chip to reduce trade barriers. President Donald Trump’s use of the import duties has broken with […]
Read More
After calling off merger, Coach parent Tapestry’s holiday sales soar
The logo of U.S. fashion brand Coach is seen in New York on Nov. 19, 2024. Charly Triballeau | AFP | Getty Images Shares of Coach parent Tapestry shot up about 15% in premarket trading after the company beat holiday-quarter sales expectations and boosted its full-year forecast. The fashion and accessories company said it now […]
Read More
Trump’s tax cuts are ‘stuck in the mud’ as Republicans split over spending
U.S. House Speaker Mike Johnson (R-LA) reacts following the passage of a spending legislation to avert a government shutdown, on Capitol Hill in Washington, U.S., December 20, 2024. Nathan Howard | Reuters President Donald Trump’s agenda is hitting speed bumps on Capitol Hill, as Republican infighting over spending levels threatens to halt a massive package […]
Read More
Shares of Peloton surge 13% as it edges closer to profitability, posts better than expected results
Peloton told investors Thursday it still has a “steep hill to climb” to achieve profitable growth under its new CEO, but the connected fitness company beat holiday sales expectations, thanks in part to its partnership with Costco. The bike maker posted mixed fiscal second quarter results, as it topped Wall Street’s sales estimates but lost […]
Read More
Amazon set to pass Walmart in revenue for first time
Amazon CEO Andy Jassy speaks during a keynote address at AWS re:Invent 2024, a conference hosted by Amazon Web Services, at The Venetian Las Vegas on December 3, 2024 in Las Vegas, Nevada. Noah Berger | Getty Images Entertainment | Getty Images Amazon long ago passed Walmart in terms of market cap, but the e-commerce […]
Read More
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty Images Eli Lilly on Thursday said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide later this year, which is a […]
Read More
Bank of England restarts monetary easing, cutting key rate to 4.5%
The Bank of England made its first interest rate cut of 2025 on Thursday, resuming monetary easing amid ongoing concerns over sluggish growth in the British economy. The central bank cut its benchmark interest rate by 25 basis points to 4.5%, with a majority of seven members out of the nine-strong monetary policy committee voting […]
Read More
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday said it will slash $2 billion in costs by the end of 2027, expanding its ongoing cost savings effort to chart a path toward long-term […]
Read More
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Eli Lilly on Thursday reported mixed results for the fourth quarter as sales of its blockbuster weight loss and diabetes drugs soared but it saw lower realized prices. The figures were consistent with the preliminary results Eli Lilly shared […]
Read More